Olympus Exercises Option to Buy Israeli Medical Device Company Medi-Tate to Drive Global Urology Business Growth～Initiate Discussion for Acquisition to expand Minimally Invasive Treatment product portfolio～
February 26, 2021
Olympus Corporation (”Olympus” – Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi) announced today that it has exercised its call option in respect of the remainder of the shares in Medi-Tate Ltd. (“Medi-Tate”, an Israeli medical device company, CEO: Ido Kilemnik). The potential acquisition would further strengthen Olympus’ Therapeutic Solutions Division, a key pillar in its future growth strategy, and solidify its position as a leader in the field of urological devices.
Press releases are company announcements that are directed at the news media.
Information posted on this site is current and accurate only at the time of their original publication date, and may now be outdated or inaccurate.